Joe Kelley
Analyst · Sidoti & Company. Please proceed with your question
Thank you, Jugal and good morning to everyone joining us on the call. My comment today will cover first quarter 2017 financial highlights, a review of profitability by segment, brief comments on the balance sheet cash flow and modeling assumptions and the earnings outlook for 2017. Starting with the financial highlights, the first quarter 2017 we reported year-over-year growth in both topline value-added sales and adjusted operating profit for the first time in the past seven quarters. First quarter 2017 adjusted earnings exceeded our internal forecast and earnings guidance provided to the street. First quarter 2017 value-added sales of $149 million increased approximately 4% versus the prior-year first quarter value-added sales of $143.9 million. The Heraeus acquisition late in the first quarter of 2017 accounted for $2.9 million of value-added sales growth, while the base historical business value-added sales grew 2% over the prior year period. As a reminder to investors, value-added sales removes the impact of pass-through precious metal cost. The company continued to experience positive momentum with new product value-added sales, which totaled $20.3 million in the quarter and grew 22% over the prior-year first quarter. A modest recovery in end market demand also continued, particularly in our two largest end markets, consumer electronics and industrial components. These favorable trends were largely offset by decreased sales into the medical and defense end markets. As you may remember, it was mentioned on the year-end earnings call that Materion's largest medical customer began the transition from a legacy product to a next-generation product in the fourth quarter of 2016. This product transition continued during the first quarter of 2017, negatively impacting year-over-year value-added sales in the medical end markets. As for sales in the defense end market, although defense sales in the first quarter of 2017 were solid in historical terms at $12.9 million, this represents approximately a 10% decrease from the prior-year first quarter, which saw very strong defense sales. As a reminder to investors, the timing of sales in the defense end market can vary quarter-to-quarter related to large government programs, particularly with respect to high purity beryllium sales. While value-added sales grew year-over-year and sequentially in the first quarter of 2017, the changing sales mix was unfavorable leading to a slight deterioration in gross margin. Selling, general and administrative expense increased $3.1 million over the prior-year first quarter of $30.5 million. Excluding nonrecurring cost related to the CEO transition, cost reduction initiatives and the acquisition and integration cost, adjusted SG&A expense was down approximately $1 million or 3% versus the 2016 first quarter and down 6% sequentially from the adjusted fourth quarter 2016. Operating profit totaled $3.4 million in the first quarter of 2017. Adjusted operating profit excluding special items was $7.7 million, a 3% improvement from the $7.5 million recorded in the prior-year first quarter and a 7% improvement from the $7.2 million of adjusted operating profit recorded in the fourth quarter of 2016. The growth in adjusted operating profit was due to sales growth and cost reduction initiatives, offset partially by unfavorable product mix. Net income for the first quarter of 2017 was $3.1 million or $0.15 per share diluted. On an adjusted basis, excluding the nonrecurring cost, first quarter 2017 earnings were $0.29 per share up 7% versus $0.27 per share in the first quarter of 2016. The first quarter 2017 effective tax rate was negative 4% as two timing issues related to executive and share-based stock compensation were recorded in the quarter. The full year 2017 effective tax rate is forecasted to be in the range of 18% to 20%. Please note the adjusted first quarter 2017 earnings per share of $0.29 is reflective of an effective tax rate of approximately 19%, comparable to the forecasted full year effective tax rate. Now, a review of our first quarter 2017 performance by business segment, starting first with advanced materials. This segment delivered value-added sales in the first quarter of 2017 totaling $47.3 million, a 12% increase over the $42.1 million recorded in the first quarter of 2016. Excluding sales related to acquisition, value-added sales increased 5% versus the first quarter of 2016. End market demand was strong across most of the segment's major end markets. Adjusted operating profit for the first quarter of 2017, excluding acquisition and integration costs was $7.4 million or 16% of value-added sales, compared to $5.2 million or 12% of value-added sales during the prior-year period. This significant 42% improvement in adjusted operating profit was due to a combination of higher sales volumes and improved product mix. This business continues to perform well. The favorable outlook for the consumer electronics end market and continued integration of the Heraeus business should serve to further bolster growth in this segment. We are now approximately 60 days into the integration of the global Heraeus business and we are pleased to report that customer, employee and operations integration initiatives are progressing on schedule. Management continues to be very excited about how this acquisition strengthens the commercial and technical capability of our advanced materials business. Now a review of performance alloy and composites. First quarter 2017 value-added sales were $79.2 million, a 1% increase from $78.2 million in the first quarter of 2016. The modest year-over-year sales increase is reflective of continued growth in strip product sales, primarily in the electronic connector market in Asia, offset by reduced sales of high purity beryllium products in defense and science applications. Adjusted operating profit in the first quarter of 2017 excluding special items related to the closure of the Japan service center was $700,000 compared to $1.5 million in the first quarter of 2016. The decrease in profitability was driven primarily by unfavorable product mix as low high-purity beryllium sales were offset by higher copper beryllium strip product sales. The results of this business segment in the first quarter of 2017 were disappointing. However, looking at the current order book and actions already initiated, both sales and profitability for this segment are forecasted to sequentially improve each quarter as we move through the remainder of the year. The business segment is on track to close the service center in Fukaya Japan at the end of the second quarter, which is expected to generate approximately $2 million of annualized savings. From a topline perspective, continued actions to improve product pricing and appropriately capture the value provided to customers are being taken. The company remains focused on maintaining a robust pipeline of new products to drive growth and improved mix. Additionally, the return of consistent raw material beryllium hydroxide sales is forecasted to resume later in 2017. As a result of the combination of all these factors and actions, quarterly value-added sales and operating profit margins for this segment are forecasted to consistently improve during 2017. Turning now to precision coatings, this segment recorded value-added sales of $23.3 million in the first quarter of 2017. This compares to $24.6 million of value-added sales in the same period last year. The decrease in value-added sales is due primarily to lower sales volume into the medical end market. As previously referenced. a significant customer began a product transition to a next-generation product late in the fourth quarter of 2016. This product shift has negatively impacted value-added sales in the past two quarters. Operating profit for the precision coatings segment totaled $2.2 million or 9% of value-added sales in the first quarter of 2017 compared to $4.1 million in the first quarter of 2016. The decrease in segment operating profit was due primarily to lower sales volume of precision coated products for blood glucose testing and unfavorable sales mix. I remind investors that the precision coatings segment has delivered four consecutive years of improving profits and the first quarter of 2016 was the peak level of profitability. Full-year 2016 profit margins as a percentage of value-added sales finished at 12%. This segment is forecasted to again deliver double-digit profitability in 2017. Turning now to the balance sheet and cash flow, the company ended the first quarter of 2017 with a net debt position of $16 million, $2 million below the prior year net debt level. Materion continues to have significant available liquidity to support meaningful organic growth opportunities further inorganic strategic growth and consistently return cash to shareholders through a combination of dividends and share buybacks. Cash flow from operations in the first quarter of 2017 was negative $16.8 million, which was consistent with the prior-year first quarter cash used due to normal seasonal investments in working capital and the timing of cash payments for annual accruals. Cash flow from investing activities includes the $16.4 million cash investment associated with the Heraeus acquisition. This amount is approximately $13 million shy of the agreed purchase price because of working capital levels and assume liabilities transferred at closing. For financial modeling purposes in 2017, cash flow from operations will run approximately $50 million to $60 million. Capital spending should run approximately $25 million to $30 million, mine development investments should be less than $3 million, annual depreciation and amortization should run approximately $43 million to $45 million and effective tax rate of approximately 18% to 20% should be assumed. And finally, now the earnings outlook for the remainder of 2017. Based on our first quarter performance and the current order entry rate, the company confirms the full year 2017 earnings guidance range of $1.45 to $1.60 per share. The midpoint of this range represents a 15% increase over 2016 adjusted earnings. The substantial sequential improvement in quarterly profitability implied by the annual guidance is driven by increased sales volume, supported by the current order entry rate, contribution from the Heraeus acquisition, resuming sales of raw material beryllium hydroxide and cost saving initiatives. Looking specifically at the second quarter 2017 earnings, we are forecasting a sequential earnings increase of approximately 25% to 35% compared to the first quarter of 2017 adjusted earnings. This concludes the review the financial performance and my prepared remarks. The line will now open for questions.